These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 756103)

  • 1. HLA system and its association to chronic hepatitis and persistence of HBsAg in the organism.
    Horejsi J; Cerhova M; Majsky A; Mimra J
    Tijdschr Gastroenterol; 1978; 21(6):457-64. PubMed ID: 756103
    [No Abstract]   [Full Text] [Related]  

  • 2. [HLA antigens in blood donors, asymptomatic chronic carriers of the viral hepatitis type B surface antigen (HBsAg)].
    Morales VH; Barbetti A; Basualdo JA; Jmelnitzky A; Landoni N; Ponce de León H; Chopita N; de Torres RA
    Medicina (B Aires); 1983; 43(2):175-80. PubMed ID: 6664285
    [No Abstract]   [Full Text] [Related]  

  • 3. [Positive HBsAg in 3 sisters carrying identical HLA].
    Marzo L; Buñuel C; Aztarain E; Raichs A
    Sangre (Barc); 1984; 29(1):93-4. PubMed ID: 6719323
    [No Abstract]   [Full Text] [Related]  

  • 4. [A family study of HBsAg carrier and major histocompatibility antigens].
    Kashiwagi S; Naito S; Kaneoka H; Miyanaga O; Jimi S; Yamaguchi M; Kaji M
    Fukuoka Igaku Zasshi; 1978 Apr; 69(4):156-61. PubMed ID: 669556
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunogenetic studies on etiology of liver disease --HLA in asymptomatic carriers with positive HBs-Ag (author's transl)].
    Morita N; Shingami T; Shiwaku Y; Mori H; Nakao Y; Hashimoto S
    Igaku Kenkyu; 1979 Sep; 49(3):249-50. PubMed ID: 547641
    [No Abstract]   [Full Text] [Related]  

  • 6. HLA antigens in chronic active hepatitis.
    Pár A; Bajtai G; Gyódi E; Ambrus M; Hernádi E; Tényi I
    Acta Med Acad Sci Hung; 1980; 37(1):17-24. PubMed ID: 7457016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histocompatibility-(HLA) antigens in patients with HBsAg positive and negative hepatitis and healthy carriers of HBsAg and anti-HBs. (author's transl)].
    Freudenberg J; Meyer zum Büschefelde KH; Arnold W; Berger J; Weiller H; Knolle J; Hopf U; Hütteroth T
    Klin Wochenschr; 1976 Jun; 54(12):579-83. PubMed ID: 940293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Variations in the expression of HLA antigens in hepatic biopsies of children with chronic HBsAg-positive hepatitis].
    Borgiani L; Calzia R; Campelli A; Marazzi MG; Piscopo R; Dorati M; Badaracco B; Puppo F; Canepa M
    Pathologica; 1988; 80(1069):551-9. PubMed ID: 3073346
    [No Abstract]   [Full Text] [Related]  

  • 9. [HBsAg in the hepatocytes in chronic liver diseases].
    Loginov AS; Aruin LI; Shepeleva SD; Tkachev VD; Zotina MM
    Ter Arkh; 1986; 58(3):71-3. PubMed ID: 3715734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunological study of carriers of Australia antigen (HBsAg)].
    Rizzetto M; Verme G
    Minerva Med; 1978 Aug; 69(38):2569-72. PubMed ID: 714258
    [No Abstract]   [Full Text] [Related]  

  • 11. [Importance of the immune system in the symptom-free HBsAg carrier state].
    Mansurov KhKh; Asfandiiarova NS
    Klin Med (Mosk); 1984 Jun; 62(6):17-21. PubMed ID: 6381874
    [No Abstract]   [Full Text] [Related]  

  • 12. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 13. Presence of delta antigen in liver biopsies of HBsAg positive patients with chronic liver diseases living in the Naples area.
    Picciotto L; Abrescia N; Ciampi R
    Boll Soc Ital Biol Sper; 1983 Jan; 59(2):189-91. PubMed ID: 6860493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The incidence of hepatitis B and HBsAg carrier state in families caused by (nonparenteral) contact].
    Horejsí J; Cerhová M; Jezková Z; Májský A; Mimra J; Novák J; Svorcová V
    Vnitr Lek; 1980 Apr; 26(4):234-41. PubMed ID: 7385610
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunogenetic studies on etiology of liver disease --HLA and chronic hepatitis (author's transl)].
    Shingami T; Morita N; Shiwaku Y; Mori H; Hashimoto S
    Igaku Kenkyu; 1979 Sep; 49(3):240-3. PubMed ID: 547639
    [No Abstract]   [Full Text] [Related]  

  • 16. [The quantitative determination of HBSAG--a valuable aid in evaluating the infectiousness of hepatitis B virus carriers].
    Löschner J; Fengler JD; Baumgarten R
    Z Arztl Fortbild (Jena); 1981 Nov; 75(22):1084-5. PubMed ID: 7340196
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunogenetic factors influencing HBV carrier state, the seroconversion and the development of chronic liver disease].
    Shimbo M; Ohtsuka S; Sakaya S; Sakamoto S; Ikeda H; Sekiguchi S
    Hokkaido Igaku Zasshi; 1990 Jan; 65(1):67-73. PubMed ID: 2328948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Superinfection with delta agent in chronic carriers of HBsAg in Spain. Clinical, epidemiologic and virologic characteristics].
    Bas L; Carreño V; Porres JC; Mora I; Gutiez J; de Torres M; Hernández Guio C
    Rev Clin Esp; 1984 Oct; 175(2):67-9. PubMed ID: 6522725
    [No Abstract]   [Full Text] [Related]  

  • 19. [HBeAg and anti-HBe levels in HBsAg positive blood donors].
    Hasçelik G; Günalp A
    Mikrobiyol Bul; 1989 Jan; 23(1):23-9. PubMed ID: 2626096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A follow-up study on HBsAg carriers and factors affecting negative-conversion].
    Hong DQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 1984 Jan; 18(1):32-4. PubMed ID: 6468123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.